LyfeMD Inc.
LyfeMD’s digital platform provides evidence-based solutions to help manage life-altering chronic digestive diseases affecting 36% of the North American population. The platform is sold using a subscription model to pharmaceutical companies and pharmacies. Developed by gastroenterologists and dietitians, LyfeMD offers proprietary lifestyle therapy programs combined with coaching and health professional support to patients in Canada and the US.